196 related articles for article (PubMed ID: 6219021)
1. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane.
Parthasarathy N; Spiro RG
Diabetes; 1982 Aug; 31(8 Pt 1):738-41. PubMed ID: 6219021
[TBL] [Abstract][Full Text] [Related]
2. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin.
Shimomura H; Spiro RG
Diabetes; 1987 Mar; 36(3):374-81. PubMed ID: 2948855
[TBL] [Abstract][Full Text] [Related]
3. Characterization of heparan sulfate isolated from drug glomerular basement membranes.
Linker A; Hovingh P; Kanwar YS; Farquhar MG
Lab Invest; 1981 Jun; 44(6):560-5. PubMed ID: 6453253
[TBL] [Abstract][Full Text] [Related]
4. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
5. Isolation of glycosaminoglycans (heparan sulfate) from glomerular basement membranes.
Kanwar YS; Farquhar MG
Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4493-7. PubMed ID: 159457
[TBL] [Abstract][Full Text] [Related]
6. Presence of heparan sulfate in the glomerular basement membrane.
Kanwar YS; Farquhar MG
Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1303-7. PubMed ID: 155819
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycan from human tubular basement membrane. Comparison with this component from the glomerular basement membrane.
van den Heuvel LP; van den Born J; Veerkamp JH; van de Velden TJ; Schenkels L; Monnens LA; Schröder CH; Berden JH
Biochim Biophys Acta; 1990 Jun; 1025(1):67-76. PubMed ID: 2164419
[TBL] [Abstract][Full Text] [Related]
8. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
Cohen MP; Klepser H; Wu VY
Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
[TBL] [Abstract][Full Text] [Related]
9. Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes.
Wu VY; Wilson B; Cohen MP
Diabetes; 1987 Jun; 36(6):679-83. PubMed ID: 3569668
[TBL] [Abstract][Full Text] [Related]
10. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
Templeton DM
Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
[TBL] [Abstract][Full Text] [Related]
11. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes.
Edge AS; Spiro RG
Diabetologia; 2000 Aug; 43(8):1056-9. PubMed ID: 10990084
[TBL] [Abstract][Full Text] [Related]
12. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
[TBL] [Abstract][Full Text] [Related]
13. Quantitative method for the determination of glycosaminoglycans from small quantities of glomerular basement membranes.
Parthasarathy N
Ren Physiol; 1985; 8(1):45-9. PubMed ID: 3969507
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.
Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM
N Engl J Med; 1983 Oct; 309(17):1001-9. PubMed ID: 6225948
[TBL] [Abstract][Full Text] [Related]
15. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
[TBL] [Abstract][Full Text] [Related]
16. Immunogold quantitation of laminin, type IV collagen, and heparan sulfate proteoglycan in a variety of basement membranes.
Grant DS; Leblond CP
J Histochem Cytochem; 1988 Mar; 36(3):271-83. PubMed ID: 2963856
[TBL] [Abstract][Full Text] [Related]
17. Alterations of glomerular basement membrane charge and structure in diabetic nephropathy.
Goode NP; Shires M; Crellin DM; Aparicio SR; Davison AM
Diabetologia; 1995 Dec; 38(12):1455-65. PubMed ID: 8786020
[TBL] [Abstract][Full Text] [Related]
18. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
19. Early increase of chondroitin sulfate glycosaminoglycan in the glomerular basement membrane of rats with diabetic glomerulopathy.
Karasawa R; Nishi S; Suzuki Y; Imai N; Arakawa M
Nephron; 1997; 76(1):62-71. PubMed ID: 9171302
[TBL] [Abstract][Full Text] [Related]
20. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
